. Cytosolic sensors, such as Nod-like receptors (NLRs) and absent in melanoma 2 (AIM2)-like receptors, are also involved in fungal sensing and host protection [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . NLRP3 and AIM2 assemble the inflammasome, a multimeric protein complex that mediates the cleavage of caspase-1, interleukin-1β (IL-1β ) and IL-18 and the induction of pyroptosis 23 . We previously showed that concerted activation of NLRP3 and AIM2 inflammasomes is required for effective caspase-1 activation and host resistance against A. fumigatus infection 17 . However, the regulation and activation of inflammasomes during A. fumigatus infection at the molecular level remain poorly understood.
Recent studies show multiple regulators of NLRP3 and AIM2 inflammasomes during cytosolic bacterial infections, such as the transcription factor interferon (IFN) regulatory factor 1 (IRF1) and downstream effector molecules of the IFN-inducible GTPase family 24 . The GTPases guanylate-binding proteins (GBPs) and immunityrelated GTPase B10 (IRGB10) target and lyse bacteria and liberate bacterial ligands, which ultimately triggers inflammasome activation [24] [25] [26] . Lipopolysaccharide (LPS) released by cytosolic bacteria leads to caspase-11-dependent activation of the non-canonical NLRP3 inflammasome 25, 27 , whereas DNA released upon bacterial lysis activates the AIM2 inflammasome [24] [25] [26] . Although the crucial role of IRF1 and IFN-inducible GTPases in inflammasome activation during bacterial infections is well established, the involvement of these proteins in inflammasome activation and host resistance during fungal infections remains to be investigated.
Results
TLRs and Dectin-1 are required for inflammasome activation during A. fumigatus infection. Host cells sense A. fumigatus via TLRs, such as TLR2 (refs 8, 28 ), TLR4 (refs 5, 9, 29 ), TLR3 (ref. 4 ) and TLR9 (refs 6, 10, 30 ), and the CLR Dectin-1 (refs 31, 32 ). However, the role of TLRs and CLRs in inflammasome activation in response to A. fumigatus infection remains unknown.
We infected unprimed wild-type (WT) 
Tlr4
−/− and Tlr2
−/−
Tlr9 −/− bone marrow macrophages (BMDMs) with A. fumigatus and assessed caspase-1 activation and IL-1β release. Cleavage of caspase-1 and the release of IL-1β were impaired in BMDMs that lacked a single TLR or multiple TLRs compared to WT BMDMs ( Supplementary Fig. 1a ,b,d,e), whereas the secretion of the inflammasome-independent cytokine tumour necrosis factor (TNF) was comparable among all genotypes ( Supplementary Fig. 1c,f) . These findings imply a key priming-independent role for TLRs in inflammasome activation upon A. fumigatus infection.
We also infected BMDMs lacking Dectin-1, a major CLR that binds to β 1-3 glucans of A. fumigatus and is required for its clearance 33 , with A. fumigatus and found decreased caspase-1 cleavage and IL-1β and TNF release, revealing a pivotal role for Dectin-1 in regulating both inflammasome priming and activation
Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection Benoit Briard 1
The SYK-CARD9-MALT1 complex regulates IRF1 expression, whereas activation of IRF1 is MyD88-TRIF dependent. IRF1 regulates inflammasome activation during cytosolic bacterial infections 24 . Activation of Dectin-1 and TLR2 promotes recruitment of IRF1 to the IFN-stimulated response element-binding site to regulate gene expression 35 . BMDMs infected with A. fumigatus showed IRF1 induction ( 
Card9
−/− and Malt1 −/− BMDMs compared to WT cells ( Fig. 2a-c ).
Irf1 expression was also reduced in Dectin1
−/− BMDMs compared to WT (Supplementary Fig. 3a ). We also assessed whether the CLR pathway transcriptionally regulates the IRF1 downstream genes Irgb10 and Gbp2, and we found significantly lower expression of Gbp2 and Irgb10 in BMDMs lacking CARD9 and MALT1 (Fig. 2d,e) . The role of NF-κ B signalling in Irf1 expression has been previously reported 36 . Because the CLR pathway regulates NF-κ B and MAPK signalling in response to A. fumigatus (Fig. 1i,j) , we assessed IRF1 induction during fungal infection in the presence of the NF-κ B inhibitor Bay 11-7082. Phosphorylation of Iκ Bα and IRF1 induction were reduced in BMDMs incubated with the NF-κ B inhibitor (Fig. 2f) . By contrast, both IRF1 mRNA and protein were similar between WT and Myd88
−/−

Trif
−/− BMDMs infected with A. fumigatus (Fig. 2g,h ), suggesting that TLR signalling is dispensable for IRF1 induction. Interestingly, despite similar Irf1 expression,
Myd88
−/−
Trif −/− BMDMs showed lower expression of Gbp2, Gbp5 and Irgb10 (Fig. 2i-k) . The interaction between IRF1 and MyD88 is important for efficient nuclear localization of IRF1 (refs 35, 37 ). Indeed, we found a reduction in IRF1 in the nuclear fraction of
A. fumigatus-infected Myd88
−/− and Trif −/− BMDMs compared to WT (Fig. 2l,m) . Furthermore, overexpression of MyD88 increased IRF1 accumulation in the nuclear fraction compared to cells transfected with the vector control ( Supplementary Fig. 3b-d ). MyD88 and IRF1 co-precipitated during A. fumigatus infection in WT BMDMs, whereas in cells lacking TRIF, the co-immunoprecipitation was reduced, although the expression of MyD88 was not affected ( Supplementary Fig. 3e,f) . These results demonstrated that the SYK-CARD9-MALT1 complex regulates IRF1 expression downstream of NF-κ B signalling, whereas MyD88 and TRIF signalling drives the nuclear translocation of IRF1. −/− and WT BMDMs (Fig. 3c) . The impaired inflammasome activation in Irf1 −/− BMDMs could not be rescued after priming with LPS and β -glucan, confirming that inflammasome priming was not affected in the absence of IRF1 (Fig. 3d,e ). IRF1 cooperates with IFN signalling and regulates the expression of IFNinducible genes, particularly those encoding GBPs and IRGB10, which are important in mediating inflammasome activation during Francisella novicida infection 24, 25 . We assessed the induction of GBP2, GBP5 and IRGB10 mRNA and protein in BMDMs after A. fumigatus infection. These GTPases were strongly induced in an IRF1-dependent manner (Fig. 3f-i) , confirming the role of IRF1 in inducing GBPs and IRGB10 in response to A. fumigatus infection.
IRF1 regulates inflammasome activation and the expression of
IRGB10, but not GBPs, contributes to the activation of inflammasomes in response to A. fumigatus. The role of GBPs and IRGB10 in activating NLRP3 and AIM2 inflammasomes has been reported in multiple models of infection 38 . To investigate the role of GBPs and IRGB10 in A. fumigatus infection, we infected BMDMs lacking either IRGB10 or GBPs located on chromosome 3, namely, GBP1, GBP2, GBP3, GBP5 and GBP7 (hereby denoted as Gbp chr3−/− ), with A. fumigatus and assessed inflammasome activation. BMDMs lacking IRGB10, but not GBPs, exhibited substantial reduction in caspase-1 activation and IL-1β release compared to WT cells infected with A. fumigatus (Fig. 4a-e) . However, IRGB10 deficiency did not affect the secretion of TNF (Fig. 4f) . Consistently, phosphorylation of ERK1/2 and Iκ Bα , and NLRP3 were similar between Irgb10 −/− and WT BMDMs (Fig. 4g) . The induction of Il1b and Tnf was also comparable between Irgb10 −/− and WT BMDMs (Fig. 4h,i) . Together, these data demonstrate that the priming signal necessary for activation of the inflammasome was not compromised in the absence of IRGB10. Moreover, caspase-1 cleavage was still impaired in primed Irgb10 −/− BMDMs compared to primed WT cells, further confirming a priming-independent role for IRGB10 ( Fig. 4j and Supplementary Fig. 4a) .
A. fumigatus engages both NLRP3 and AIM2 inflammasomes, and IRGB10 is known to be required for their activation during bacterial infection. To decipher whether the NLRP3 or AIM2 inflammasome contributes to the residual caspase-1 cleavage in Irgb10 −/− BMDMs (Fig. 4d) , we inhibited the NLRP3 inflammasome with specific NLRP3 inhibitors, and caspase-1 cleavage was completely abolished in both conditions, suggesting that the NLRP3 inflammasome contributed to the residual caspase-1 cleavage in Irgb10 −/− BMDMs ( Supplementary Fig. 4b,c) . The observed reduction in inflammasome activation could also be due to a defect in the phagocytosis and killing of conidia in Irgb10 −/− BMDMs. WT and Irgb10
−/− BMDMs showed comparable capability to phagocytose and kill resting conidia ( Fig. 4k and Supplementary Fig. 4d ). However, Irgb10 −/− BMDMs demonstrated a reduced capacity to inhibit hyphae growth (Fig. 4l) . Together, these results suggest 
Malt1
-/- [38] [39] [40] .
We previously showed that GBPs and IRGB10 target the outer membrane of Escherichia coli and F. novicida to release bacterial ligands and thereby facilitate inflammasome activation 24, 25 . To investigate whether IRGB10 also targets A. fumigatus, we immunostained endogenous IRGB10 along with the fungal cell wall component chitin in BMDMs infected with the fungi. IRGB10 was induced upon A. fumigatus infection compared to unstimulated BMDMs ( Fig. 3f-i and Supplementary Fig. 5a ,b) and IRGB10 puncta accumulated around the cell wall of A. fumigatus ( Supplementary Fig. 5b ). The fluorescence projection revealed peak signals of IRGB10 immunostaining and the fungal cell wall staining superposed with each other (Supplementary Fig. 5c ).
A. fumigatus is a pulmonary pathogen that can infect both immune and non-immune cells 17, 41 . IRGB10 expression was upregulated in primary lung fibroblasts upon infection with A. fumigatus in an IRF1-dependent manner ( Supplementary Fig. 5d ,e). Consistent with our observation in BMDMs, IRGB10 localized on the fungal cell wall in primary lung fibroblasts infected with A. fumigatus, suggesting a role for IRGB10 in both immune and non-immune cells ( Supplementary Fig. 5f ,g), and distinct puncta of IRGB10 surrounding the A. fumigatus cell wall were observed ( Fig. 5a-c) . Similar to endogenous IRGB10, mCherry-tagged IRGB10 colocalized with the A. fumigatus cell wall ( Supplementary Fig. 5h,i ). These observations indicate that the targeting of the fungal cell wall, which causes the release of ligands, is the potential mechanism by which IRGB10 promotes inflammasome activation and host defence against A. fumigatus. IRGB10 peptides inhibit A. fumigatus and liberate fungal ligands that induce inflammasome activation. The role of IRGB10 in inflammasome activation has been reported, but its mode of action has not been explained 25 . Bioinformatic analysis of IRGB10 revealed two putative transmembrane helices with antimicrobial properties 25 . Furthermore, we identified a new antimicrobial stretch between residues 170 and 186 with a low probability of misclassification ( Supplementary Fig. 6a,b) . Indeed, this putative antimicrobial stretch is highly conserved among other members of the IRG family ( Supplementary Fig. 6c ). However, in comparison to all of the other IRG family members for putative antifungal function, IRGB10 , presented relative to that of the gene encoding β -actin. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 (one-way ANOVA with Dunnett's multiple comparisons test and Sidak's multiple comparisons test); data show the mean ± s.e.m. (b,c,g-i). Data are representative of at least two independent experiments (a-l). The exact P values are represented in Supplementary Table 3. revealed the strongest antimicrobial (antifungal, antibacterial and antiviral) activity ( Supplementary Fig. 6d,e) . Based on our analysis, we synthesized the putative antimicrobial peptides ( Supplementary  Figs. 6f and 7a-f ) and investigated their antifungal activities against A. fumigatus. The two putative transmembrane carboxy-terminal peptides (1 and 2) showed antifungal activity against A. fumigatus, whereas the scramble peptides 1 and 2 did not (Fig. 5d) . In addition, peptide 3, which contains the putative antimicrobial stretch, 
A.f (h)
A.f (h) demonstrated antifungal activity and inhibited the growth of A. fumigatus. However, a similar effect was also observed with the scramble peptide 3 (Fig. 5e ). This could be owing to the structural properties of the scrambled peptide, as the prediction method for the antimicrobial stretch was based on the amino acid composition and not its sequence or three-dimensional structure. To further confirm the specific activity of these peptides, we selected two random IRGB10 peptides and tested their antifungal activity ( Supplementary Figs. 6f and 8a-d) . These random peptides did not show any inhibitory activity against A. fumigatus (Fig. 5f ). Although IRGB10 peptides induced hyphal damage, we did not observe any fungicidal activity on A. fumigatus resting conidia (Fig. 5g,h ). This is in line with the activity observed previously in Irgb10 −/− BMDMs (Fig. 4k,l) . We further confirmed by scanning electron microscopy that the surfaces of hyphae were compromised by IRGB10 peptides compared to the control peptides (Fig. 5i) . This led us to hypothesize Casp-1, p45 ) and the caspase-1 subunit p10 (Casp-1, p10) of lung homogenates after 4 days of infection with A. fumigatus resting conidia. h, Levels of IL-1β and IL-6 in lung homogenates after 2 days of infection with A. fumigatus resting conidia. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001, log-rank (Mantel-Cox) test (a,b), Mann-Whitney test two-tailed P value (f) and unpaired t-test two-tailed P value (h). Data shown the mean ± s.e.m. (f,h). Data are from two independent experiments (a,b) and data are representative of at least one experiment (c-h). The exact P values are represented in Supplementary Table 3. that IRGB10 peptides induce the release of fungal pathogen-associated molecular patterns to activate the inflammasomes. Either the fungal polysaccharides or the DNA released into the cytoplasm by IRGB10 during intracellular A. fumigatus growth would lead to inflammasome activation. A. fumigatus DNA has been shown to engage the AIM2 inflammasome 17 ; however, the role of fungal polysaccharides released into the cytoplasm in inducing inflammasome activation has not been explored. Transfection of β -glucan directly into the cytoplasm activated caspase-1 (Fig. 5j) . However, the capability of β -glucan to activate the inflammasome still required IRGB10, indicating an IRGB10-dependent mechanism acting on β -glucan to facilitate inflammasome activation. Together, these data indicate that the antimicrobial activity of IRGB10 disrupts the fungal cell wall, leading to the release of polysaccharides that facilitate inflammasome activation. The cell wall damage could possibly lead to lysis of the fungal cell wall and subsequent release of DNA.
IRGB10 provides host protection against infection with A. fumigatus in vivo.
We previously reported the crucial physiological role of inflammasomes in host defence during aspergillosis 17 . Thus, we investigated the role of GBPs and IRGB10 in inflammasomemediated antifungal responses during A. fumigatus infection. Both WT and Gbp chr3−/− mice showed similar susceptibility to A. fumigatus infection, and the mortality rate was less than 50% (Fig. 6a) . However, the mortality rate was significantly increased in IRGB10-deficient mice and approximately 90% of Irgb10 −/− mice succumbed to A. fumigatus infection (Fig. 6b) . The lungs of mice lacking IRGB10 showed a higher extent of gross pathology and haemorrhage than did the lungs of WT mice (Fig. 6c) . In addition, Gomori methenamine silver staining showed that A. fumigatus infection in mice lacking IRGB10 resulted in necrotizing invasive lesions, whereas the infection in WT mice was largely restricted to airway lumens (Fig. 6d, 
e). The lungs of infected Irgb10
−/− mice showed transmural inflammation and necrosis of bronchioles, blood vessels and alveolar septa, with marked intravascular accumulation of inflammatory cells in affected areas but limited extravasation of predominantly histocytic (macrophages) inflammation (Fig. 6d,e) .
These necrotizing lesions in Irgb10
−/− mice were also associated with interstitial and luminal haemorrhage, oedema and widespread vascular invasion by intact fungal hyphae (Fig. 6d ,e, yellow arrowheads). By contrast, A. fumigatus infection in WT lungs was generally restricted to the lumens of terminal airways and adjacent alveoli, with lesions characterized by fungal hyphae surrounded by dense cellular exudates consisting of mixed degenerating and intact neutrophils and macrophages (Fig. 6d,e, yellow arrowheads) . These suppurative inflammatory exudates completely surrounded the fungal hyphae, which were often disrupted (Fig. 6d,e) . Although there was limited necrosis of some bronchiolar epithelial cells in affected airways, there was no sign of transmural invasion or necrosis of alveoli, bronchioles or blood vessels and interstitial haemorrhage and oedema in WT lungs. These results collectively demonstrate that IRGB10 promotes more-effective host immune responses to pulmonary A. fumigatus infection, which reduces mortality by preventing vascular invasion and dissemination of the infection. In line with the staining, we observed a significantly higher 18S rRNA level in the lungs of Irgb10 −/− mice than WT mice (Fig. 6f) . Consistent with our in vitro findings, caspase-1 cleavage and IL-1β release were impaired in the lungs of Irgb10 −/− mice compared to WT mice. By contrast, the concentration of the pro-inflammatory cytokine IL-6 was higher in Irgb10 −/− mice than in WT mice (Fig. 6g,h ). IRGB10 was required in both the stromal and the haematopoietic compartments for protection during pulmonary aspergillosis, as previously observed in mice lacking both NLRP3 and AIM2 (ref. 17 ) (Supplementary Fig. 9c ). Similar to mice lacking inflammasome components 42 ,
Irgb10
−/− immunocompetent mice were not susceptible to A. fumigatus ( Supplementary Fig. 9a,b) . These results collectively demonstrate that IRGB10 mediates immune responses in the lungs, thereby restricting fungal dissemination and promoting host defence during aspergillosis via regulation of the inflammasomes.
Discussion
In this study, we delineated how two distinct innate immune sensing pathways coordinately regulate the activation of inflammasomes upon A. fumigatus infection 17 . We identified that IRGB10, under the regulation of IRF1, plays a critical role in promoting inflammasome activation by releasing fungal ligands (Supplementary Fig. 10 ). During Candida albicans infection, yeast pathogen-associated molecular patterns are recognized by TLR2 and Dectin-1 receptors to engage the NLRP3 inflammasome 16 . Dectin-1 and particularly Dectin-2 are also required for efficient activation of the NLRP3 inflammasome during Histoplasma capsulatum infection 43 . Although it is known that A. fumigatus exposes myriads of pathogen-associated molecular patterns recognized by TLR2, TLR3, TLR4, TLR9 and Dectin-1 (refs [4] [5] [6] 8, 44 ), whether these pattern recognition receptors engage the inflammasomes upon infection with A. fumigatus remained unclear. We determined the central role of these receptors in regulating inflammasome activation during A. fumigatus infection. We previously reported that mice lacking components of inflammasomes are highly susceptible to A. fumigatus infection 17 . Furthermore, mice lacking TLR2, TLR3, TLR4 and Dectin-1 are susceptible to aspergillosis 4, 12, 13, 22 , which might be due to defective inflammasome activation (Supplementary Table 1) .
Here, we show that downstream of TLRs and Dectin-1, their respective adaptors MyD88/TRIF and the SYK-CARD9-MALT1 complex are also required for optimal inflammasome activation in response to A. fumigatus (Supplementary Table 1 ). The CLR-SYK pathway, rather than the TLR-MyD88 axis, is predominantly involved in the activation of ERK and NF-κ B during sensing of fungal ligands 45, 46 . Intriguingly, despite normal expression of IRF1 in the absence of TLR-mediated signalling through SYK-CARD9-MALT1, inflammasome activation is still reduced during A. fumigatus infection. Critically, our data indicated that TLR-mediated signalling is required for the activation of IRF1, revealing the mechanism by which the CLR and TLR pathways coordinately prime inflammasome activation during A. fumigatus infection.
Members of the IFN-inducible GTPase family, including GBPs and IRGB10, are known target genes of IRF1. GBPs and IRGB10 target the bacterial cell membrane, leading to the release of bacterial ligands and subsequent inflammasome activation 24, 25 . Although both GBPs and IRGB10 are induced in an IRF1-dependent manner upon A. fumigatus infection, only IRGB10 is required for inflammasome activation, unlike in the case of bacterial infections, in which both are necessary for optimal inflammasome activation [24] [25] [26] . These observations provide an excellent example of how the innate immune system tailors a unique, pathogen-specific response using common regulator or effector proteins 47 . In line with our findings, it has been shown that IRGB10 is necessary for optimal NLRP3 and AIM2 inflammasome activation during bacterial infection by facilitating the release of LPS from E. coli and DNA from F. novicida 25 . IRGB10 possesses putative myristoylation motifs, transmembrane amphipathic helices and antimicrobial stretches that are involved in membrane attachment and permeabilization. Among these, we demonstrated that peptides derived from the antimicrobial stretches of IRGB10 inhibited fungal growth, induced hyphae damage and modified the A. fumigatus surface. We also showed that β -glucan, one of the major components of the fungal cell wall, is able to directly activate inflammasomes. Thus, we propose a model in which IRGB10 targets the fungal cell wall and facilitates the release of ligands for inflammasome activation. However, which inflammasome (NLRP3 or AIM2) requires IRGB10 for its activation during A. fumigatus infection remains unknown. The residual activation of the NLRP3 inflammasome in Irgb10 −/− cells was perhaps dependent on the potassium efflux caused by the growth of fungal hyphae. We also show that IRGB10 colocalizes with the fungal cell wall and inhibits hyphae growth, but the mechanism by which IRGB10 is recruited to the fungal cell wall and facilitates the release of ligands remains unclear. The specific component of the fungal cell wall targeted by IRGB10 is also not known and warrants further investigation. In conclusion, our study revealed the molecular mechanisms by which innate immune sensors promote inflammasome activation during fungal infection and identified the transcription factor IRF1 and the GTPase IRGB10 as mediators of inflammasome activation during A. fumigatus infection. ).
Methods
Mice. Tlr2
In vitro stimulation of granulocyte-macrophage colony-stimulating factorderived BMDMs. Granulocyte-macrophage colony-stimulating factor-derived BMDMs were prepared as previously described 62 . In brief, bone marrow cells were grown in RPMI (10-040-CV, cellgro, Corning) supplemented with 10% FBS (TMS-013-B, lot number QVP1404280, Millipore or S1620, lot number 221C16, BioWest), 1% penicillin-streptomycin, 1% non-essential amino acids, 1% sodium pyruvate, 0.1% β -mercaptoethanol and 20 ng ml -1 granulocyte-macrophage colony-stimulating factor for 7 days. BMDMs (3 × 10 6 ) were seeded in 12-well cell culture plates (3513, Costar) in DMEM (11995-065, Gibco) supplemented with 10% FBS and 1% penicillin-streptomycin and infected with A. fumigatus conidia at a multiplicity of infection (MOI) of 20 for 20 h. For priming, BMDMs were incubated with 100 ng ml -1 LPS (tlrl-smlps, Invivogen) or 25 μ g ml -1 curdlan (C7821, Sigma) for 3 h and washed before infecting with A. fumigatus as described above. For polysaccharide transfection, 20 μ g curdlan from Alcaligenes faecalis (C7821, Sigma) was resuspended in PBS and mixed with Xfect (631318, Takara) as per the manufacturer's protocol. The reaction mixture was added to BMDMs in Opti-MEM (31985-070, Thermo Fisher Scientific).
In vitro isolation, culture and infection of lung fibroblasts. Lung fibroblasts were prepared from mouse lungs as previously described 63 . Briefly, the lungs were harvested, cut into small pieces and suspended in 0.25% trypsin lysis buffer (25200-056, Gibco) for 30 min at 37 °C under agitation. Lung fibroblast medium, composed of DMEM, 10% FBS, 1% penicillin-streptomycin, 1% non-essential amino acids, 1% sodium pyruvate, 1% HEPES buffer, 1% l-glutamine and 0.25% β -mercaptoethanol, was added to the suspension. Cell suspensions were centrifuged at 1,500 r.p.m. for 5 min and pellets were resuspended in lung fibroblast medium and plated onto culture dishes.
In vivo A. fumigatus infection. The sample size for in vivo experiments was constrained by the availability of animals. Mice were selected based on age and sex. In vivo experiments used male and female mice that were 7-8 weeks of age. Mice were infected with A. fumigatus as previously described 64 . Briefly, cyclophosphamide monohydrate (C0768, Sigma) was dissolved in sterile PBS and administered intraperitoneally (150 mg per kg of body weight). Cortisone 21-acetate (C3130, Sigma) was suspended in 0.1% Tween-20 in PBS and subcutaneously injected (112 mg per kg of body weight). Mice were given a combination of cyclophosphamide and cortisone acetate 2 days before infection and on the day of infection for the immunocompromised model of pulmonary aspergillosis or directly infected without cyclophosphamide and cortisone acetate treatment for the immunocompetent model. Mice were anaesthetized by isoflurane inhalation and inoculated intranasally with 5. Bone marrow chimeras. Mice were subjected to a single dose of irradiation (1,000 rad). Mice were retro-orbitally injected with 10 7 bone marrow cells from the femur and tibia of donor mice 2 h after irradiation. The reconstitution rate was evaluated 6 weeks after bone marrow transfer by flow staining of CD45.1 and CD45.2 in blood leukocytes, which was at least 95%. Mice were infected as described above 6 weeks post-bone marrow transfer.
Immunoblotting analysis. To check for caspase-1 cleavage by western blot analysis, cells and supernatants were lysed in caspase lysis buffer and sample loading buffer containing SDS and 100 mM dithiothreitol. To check for signalling molecules, BMDMs were lysed in 1× RIPA buffer and sample loading buffer as described previously 17 . For IRF1 nuclear localization experiments, this was followed by nuclear/cytoplasmic protein extraction with the NE-PER Kit (78835, Thermo Fisher Scientific) according to the manufacturer's protocol. Lung tissues were homogenized in PBS containing protease inhibitors (Roche). Homogenates were then mixed in a 1/1 ratio with 2× RIPA buffer, and protein concentrations were determined and diluted to 1 μ g μ l -1 with the sample loading buffer. Proteins (15 μ g) were separated on 8-10% or 12% polyacrylamide gels. After electrophoretic transfer of protein onto PVDF (polyvinylidene fluoride) membranes (Millipore), membranes were blocked in 5% skim milk and incubated with primary antibodies against caspase-1 (AG-20B-0042, Adipogen), caspase-1 p10 (sc-515, Santa Cruz), IRF1 (D5E4, Cell Signaling), GBP2 (11854-1-AP, Proteintech), GBP5 (13220-1-AP, Proteintech), IRGB10 (ref. mCherry-IRGB10 lentiviral expression. The amino-terminal mCherry-IRGB10 fusion construct was constructed using the NEBuilder HiFi DNA assembly kit (E2621S, New England BioLabs) according to the manufacturer's protocol. PCR products were generated for mCherry (5′ -AGAAGATTCTAGAGCTAGCGatggtgagcaagggcgag-3′ and 5′ -cttgtacagctcgtccatgcc-3′ ) and Irgb10 (5′ -ggcatggacgagctgtacaagatgggtcagtcttcttctaaac-3′ and 5′ -gcggatccgatttaaattcgTTACTCAGAGTCCACACTGTC-3′ ), and the vector backbone pCDH-CMV-MCS-EF1a-GFP-Neo (modified from CD516B-2, System Biosciences) was digested by EcoRI and treated with phosphatase to prevent religation. To generate lentiviral particles, the plasmids psPAX2 (12260, Addgene), pMD2.G (12259, Addgene) and the mCherry-IRGB10-containing transfer plasmid were co-transfected into 293T cells. Viral particle-containing supernatant plus polybrene (6 μ g ml -1 ) was used to transduce Irgb10 −/− primary mouse fibroblasts. Transduced cells were selected with G418 (400 μ g ml -1 , A1720, Sigma-Aldrich) to generate fibroblasts expressing mCherry-tagged IRGB10.
Real-time qRT-PCR analysis. RNA was extracted using TRIzol (15596026, Thermo Fisher Scientific) and converted into cDNA by using the High-Capacity cDNA Reverse Transcription Kit (4368814, Applied Biosystems). Real-time quantitative PCR was performed on an ABI 7500 real-time PCR instrument with 2× SYBR Green (4368706, Applied Biosystems). Real-time quantitative RT-PCR sequences used for the study are described in Supplementary Table 2.
Phagocytosis and conidiocidal assays. The phagocytosing ability per BMDM was determined by calculating the number of BMDMs that had one or more conidia phagocytosed after 1 h of infection with 10 MOI of A. fumigatus resting conidia. The conidiocidal activity of IRGB10 peptides was calculated by infecting BMDMs with 1 MOI of resting conidia and incubating with the corresponding concentration of IRGB10 peptides for 5 h. Following this, cells were lysed with 0.1% Triton X-100, plated on LB petri dishes and the number of colony-forming units was counted.
Peptide susceptibility assay. The susceptibility of A. fumigatus to IRGB10 peptides was undertaken by measuring the minimal inhibitory concentration of each peptide in 96-well flat bottom plates, as previously described 67 .
Hyphae damage assay (XTT assay). The susceptibility of A. fumigatus to BMDMs and IRGB10 peptides was determined using the protocol described in Shepardson et al. 68 and Loures and Levitz
69
.
Cytokine analysis. Cytokine levels were determined by multiplex ELISA (MCYTOMAG-70K, Millipore) according to the manufacturer's instructions.
Immunofluorescence staining. For immunofluorescence staining, BMDMs (1 × 10 6 ) or lung fibroblasts (1 × 10 5 ) were seeded on 4-well, 15-μ m slides (80426, ibidi), in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin and infected with A. fumigatus conidia with a MOI of 20 for the indicated time. Cells were washed three times and fixed in 4% paraformaldehyde for 15 min at room temperature, followed by blocking in PBS containing 10% goat serum (PCN5000, Life Technologies) supplemented with 0.2% saponin (47036, Sigma-Aldrich) for 1 h at room temperature. IRGB10 was stained using an affinity-purified polyclonal rabbit anti-IRGB10 antibody (1:1,000 dilution) overnight at 4 °C 65 .
The antibody was further purified by pre-absorption with cell lysates from IFN-γ -stimulated Irgb10 −/− BMDMs. Next, cells were washed four times with PBS and stained with an anti-rabbit secondary Alexa Fluor 568 antibody (1:250 dilution, A11036, Invitrogen) in PBS containing 10% goat serum supplemented with 0.2% saponin for 1 h at room temperature. The A. fumigatus cell wall was stained with PBS supplemented with 10 μ g ml -1 calcofluor white (18909, Sigma) for 1 h at room temperature. Cells were visualized and imaged using a Nikon C2 confocal microscope, and super-resolved three-dimensional images were taken on a Zeiss Elyra PS.1 microscope using the structured illumination microscopy technique. Pictures were analysed and aligned by Imaris (Bitplane's core scientific software).
Scanning electron microscopy. A. fumigatus was pre-grown 16 h before incubation with IRGB10 peptides for 5 h. Coverslips were fixed in a mixture of 2.5% glutaraldehyde (16200, Electron Microscopy Sciences (EMS)), 2% paraformaldehyde (15700, EMS) in 0.1 M sodium cacodylate buffer (pH 7.4) (12310, EMS). Samples were then rinsed in 0.1 M sodium cacodylate buffer four times for 5 min each, followed by a secondary fixation in 1% osmium tetroxide (19140, EMS) in ultrapure water for 60 min. The samples were then rinsed four times in ultrapure water for 5 min each, followed by dehydration in a graded ethanol series (30%, 50%, 70%, 90% and 100%, × 2) for 10 min each step. The coverslips were then loaded into a critical point drier (Autosamdri 931.GL, Tousimis), which was set to perform multiple liquid CO 2 exchanges in three 10-min 'purge' cycles with stasis mode. Once dried, the coverslips were mounted on aluminum stubs using conductive carbon adhesive tabs (77825-06, EMS), with the edges being painted with conductive silver paint (16062, Ted Pella) to reduce charging, and sputter coated with ~8 nm of iridium (Desk V, Denton Vacuum). The samples were then loaded into the Teneo VS SEM (FEI-Thermo Fisher) and imaged.
Amino acid sequence analysis. Putative antimicrobial regions in the IRGB10 amino acid sequence were predicted using AMPA algorithm with a 0.25 threshold 70 . Next, the homologue sequences of the IRG family members were analysed with iAMPpred to confirm the antimicrobial (antifungal, antibacterial and antiviral) activity 71 . Conservation at each residue position of the predicted antimicrobial stretch was graphically plotted using WebLogo3 (ref. 72 ).
Peptide biosynthesis. IRGB10 peptides (1, 2, 3 and scrambles; Supplementary Table 3) were synthesized in the Hartwell Center of St. Jude Children's Research Hospital using standard Fmoc chemistry on a Protein Technologies Symphony X instrument. Following synthesis, peptides were cleaved off the resin using TFA/ water/thioanisole/TIS/phenol/EDT and precipitated in ice-cold diethyl ether. After centrifugation, peptides were dissolved in water and lyophilized. Highperformance liquid chromatography analysis was performed on a Waters Alliance 2695 separation module and mass spectrometry was recorded using MALDI (matrix-assisted laser desorption/ionization) on a Bruker Microflex instrument. High-performance liquid chromatography purification was performed on a Waters Preparative High-Performance Liquid Chromatography System. Statistical analysis. GraphPad Prism 7.0 was used for data analysis. Data are represented as the mean ± standard error of the mean (s.e.m.). Significance was determined by a log-rank test. P < 0.05 was considered significant. The exact P values are represented in Supplementary Table 3 .
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding author upon request.
1 nature research | life sciences reporting summary Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design
Sample size
Describe how sample size was determined.
The sample size for in vivo and in vitro was constrained by availability of animals and cells. The number of independent experiments and technical replicates in both in vivo and in vitro is mentioned in the respective figure legends.
Data exclusions
Describe any data exclusions.
Outlier presence was determined via ROUT test using GraphPad PRISM.
Replication
Describe whether the experimental findings were reliably reproduced.
Data reproducibility was confirmed in multiple independent experiments as mentioned in respective figure legends.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Mice were selected based on age and sex. In vivo experiments used male and female mice that were 7 to 8 weeks of age.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
There was no blinding in our experiments.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
